Novel small-molecule inhibitors of arylamine N-acetyltransferases: drug discovery by high-throughput screening.
Arylamine N-acetyltransferases (NATs) are a family of enzymes found in eukaryotes and prokaryotes. While the precise endogenous function of NAT remains unknown for most organisms, recent evidence has shown that the expression of human NAT1 is up-regulated in estrogen receptor positive breast cancer....
Main Authors: | Westwood, I, Kawamura, A, Russell, A, Sandy, J, Davies, S, Sim, E |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2011
|
Registos relacionados
-
Selective small molecule inhibitors of the potential breast cancer marker, human arylamine N-acetyltransferase 1, and its murine homologue, mouse arylamine N-acetyltransferase 2.
Por: Russell, A, et al.
Publicado em: (2009) -
Structure and mechanism of arylamine N-acetyltransferases.
Por: Westwood, I, et al.
Publicado em: (2006) -
Synthesis and in vitro evaluation of novel small molecule inhibitors of bacterial arylamine N-acetyltransferases (NATs).
Por: Brooke, E, et al.
Publicado em: (2003) -
Differences between murine arylamine N-acetyltransferase type 1 and human arylamine N-acetyltransferase type 2 defined by substrate specificity and inhibitor binding
Por: Laurieri, N, et al.
Publicado em: (2014) -
Eukaryotic arylamine N-acetyltransferase. Investigation of substrate specificity by high-throughput screening.
Por: Kawamura, A, et al.
Publicado em: (2005)